dystrophin gene no relation medication
Ataluren, sold under the brand name Translarna, is a medication for the treatment of Duchenne muscular dystrophy.  It was designed by PTC Therapeutics.Medical use
Ataluren is used in the European Union to treat people with Duchenne muscular dystrophy who have a nonsense mutation in the dystrophin gene, can walk, and are more than five years old.
no relation